Search A Light In The Darkness

Friday, 21 February 2020

Clinical trials of intravenous vitamin C treatments for coronavirus commence in China

[Natural News]: Researchers in China have begun clinical trials on the use of intravenous vitamin C as a remedy for the Wuhan coronavirus (CoVid-19).

While government health authorities focus on pharmaceuticals and vaccines, Dr. Richard Cheng and his colleagues are investigating the simplicity with which injecting natural vitamin C can help to prevent the deadly outcomes increasingly associated with this novel disease.

One of the key mechanisms for fatality associated with the Wuhan coronavirus (CoVid-19) is its propensity to cause acute organ failure, and especially pulmonary failure or acute respiratory distress syndrome (ARDS). The rapid release of free radicals, cytokines, and other damaging hallmarks of ARDS creates an onslaught of oxidative stress that can lead to cellular injury, organ failure, and/or death.

Intravenous vitamin C, however, being a powerful antioxidant, can prevent this type of oxidative damage and cytokine storm by minimizing their impact, increasing a patient’s chances of survival and full recovery.

Of the 138 confirmed cases that Dr. Cheng and his colleagues looked at, 26 percent had to be admitted to an intensive care unit (ICU), while 4.3 percent died. Out of 99 other confirmed cases they looked at, 17 percent of patients developed ARDS, and among these, 11 percent experienced dramatically worsened symptoms over a short period of time that led to multiple organ failure and death.

“Increased oxidative stress, an underlying ‘cytokine storm,’ leads to ARDS which is the key pathology of high mortality of these pandemic viral infections,” Dr. Cheng and his colleagues write. “Cytokine storm-induced ARDS is the key pathology leading to death of these patients. Intravenous vitamin C effectively counters oxidative stress.” ..<<<Read The Full Article Here>>>....